# CBIS-DDSM Stage 16.0 — DenseNet and EfficientNet Implementation Readiness Audit

**Audit Date:** 2026-10-21  
**Project:** MSc IT (Artificial Intelligence) — CBIS-DDSM Breast Cancer Classification  
**Scope:** Pre-implementation architectural, data-pipeline, memory, and protocol readiness assessment for DenseNet and EfficientNet transfer learning  
**Target Hardware:** NVIDIA GeForce RTX 2050 (4 GB VRAM, CUDA 12.4)  
**Readiness Verdict:** **PASS** (All prerequisites satisfied, architecture verified, zero blockers)

---

## 1. Executive Readiness Summary

| Evaluation Area | Audit Requirement | Verified Capability | Readiness Status |
|---|---|---|:---:|
| **Dataset Splits** | Direct reuse of Stage 13 manifests without modification | 2,239 Train, 542 Val, 644 Test, 143 Quarantined verified | **PASS** |
| **Patient Leakage** | Complete partition isolation across train, val, and test | 0 patient overlap confirmed across all partitions | **PASS** |
| **Label Mapping** | Binary diagnosis targets consistent with Stages 14/15 | 0 = Benign, 1 = Malignant (identical `pos_weight = 1.447`) | **PASS** |
| **Grayscale Adaptation** | Single-channel 256×256 input compatibility | Channel weight averaging ($W_{\text{gray}} = \text{mean}(W_{\text{rgb}})$) verified for DenseNet & EfficientNet | **PASS** |
| **Architectural Scope** | Compatible torchvision models for 4 GB VRAM | DenseNet-121 (~7.0M params) and EfficientNet-B0 (~4.0M params) | **PASS** |
| **Memory Strategy** | Execution within 4 GB VRAM budget | Batch size 8, Grad Accum 2 (effective 16), AMP mixed precision | **PASS** |
| **Checkpoint Policy** | Validation-loss primary checkpoint + distinct AUC logging | Best-loss primary checkpoint with separate best-AUC tracking | **PASS** |
| **Test Set Isolation** | Clean test partition held back unblinded until Stage 17 | `evaluate_test = False` enforced by default | **PASS** |
| **Prior Stages Integrity** | Immutability of Stages 1–15 artifacts and metrics | All prior metadata, configs, and checkpoints untouched | **PASS** |

---

## 2. Dataset Reuse & Label Mapping Parity

### 2.1 Manifest Reuse
Stage 16 requires **zero rebuilds or alterations** of the classification manifests. It directly ingests the Stage 13 audited partitions from [`data/metadata/stage13/`](file:///c:/Users/swapn/Project/Breast_Cancer/cbis-ddsm-breast-cancer/data/metadata/stage13/):
- **Training Partition** (`classification_train_manifest.csv`): **2,239 records** (1,324 Benign, 915 Malignant). Used exclusively for gradient optimization.
- **Validation Partition** (`classification_val_manifest.csv`): **542 records** (312 Benign, 230 Malignant). Used exclusively for early stopping, learning rate scheduling, and model selection.
- **Clean Test Partition** (`classification_test_manifest.csv`): **644 records** (387 Benign, 257 Malignant). **Held back unblinded** until multi-model evaluation in Stage 17.
- **Quarantined Conflict Records** (`quarantined_conflict_manifest.csv`): **143 records** (31 patients with cross-partition conflicts). Strictly excluded.

### 2.2 Class Weighting & Loss Parity
- Binary Label Mapping:
  $$\text{Label} = 0 \implies \text{Benign}, \quad \text{Label} = 1 \implies \text{Malignant}$$
- Positive Class Weighting:
  $$w_{\text{pos}} = \frac{N_{\text{train, benign}}}{N_{\text{train, malignant}}} = \frac{1324}{915} \approx \mathbf{1.446995}$$
- Loss Function: `nn.BCEWithLogitsLoss(pos_weight=torch.tensor([1324.0 / 915.0]))`.
- Identical to Stage 14 (Baseline CNN) and Stage 15 (ResNet-50), ensuring rigorous scientific parity.

---

## 3. Input Preprocessing & Grayscale Channel Adaptation

### 3.1 Input Tensor Consistency
- Mammograms are natively single-channel grayscale images downscaled to $256 \times 256$ in Stage 5.
- The Stage 14 DataLoader pipeline (`src/datasets/stage14_dataloader.py`) supplies normalized tensors of shape:
  $$\mathbf{X} \in \mathbb{R}^{B \times 1 \times 256 \times 256}$$
- No change to spatial resolution or preprocessing is needed or permitted.

### 3.2 Channel Weight Averaging Strategy
To avoid triplicating image data in VRAM (3× tensor memory overhead), both candidate models adapt their initial convolutional layer to `in_channels = 1` using **channel weight averaging**:
$$W_{\text{gray}} = \frac{1}{3} \sum_{c=1}^3 W_{\text{rgb}}^{(c)} = W_{\text{rgb}}.\text{mean}(\text{dim}=1, \text{keepdim}=\text{True})$$

1. **DenseNet-121 Adaptation**:
   - Original first layer: `model.features.conv0` (Conv2d: $3 \to 64$, kernel 7×7, stride 2, padding 3).
   - Adapted layer: `Conv2d(1, 64, kernel_size=7, stride=2, padding=3, bias=False)`.
   - Weights: $W_{\text{gray}} \in \mathbb{R}^{64 \times 1 \times 7 \times 7}$ initialized via channel mean.
2. **EfficientNet-B0 Adaptation**:
   - Original first layer: `model.features[0][0]` (Conv2d: $3 \to 32$, kernel 3×3, stride 2, padding 1).
   - Adapted layer: `Conv2d(1, 32, kernel_size=3, stride=2, padding=1, bias=False)`.
   - Weights: $W_{\text{gray}} \in \mathbb{R}^{32 \times 1 \times 3 \times 3}$ initialized via channel mean.

*Mathematical Rationale:* Grayscale luminance $I \approx (R+G+B)/3$. Averaging the RGB filters preserves the activation magnitude and early edge-detection frequency response of ImageNet pretrained features, preventing gradient shocks during early epochs.

---

## 4. Architectural Compatibility & VRAM Assessment (RTX 2050 4 GB)

### 4.1 Comparative Model Specifications

| Attribute | Baseline CNN (Stage 14) | ResNet-50 (Stage 15) | DenseNet-121 (Stage 16) | EfficientNet-B0 (Stage 16) |
|---|:---:|:---:|:---:|:---:|
| **Model Class** | Shallow Custom CNN | Deep Residual Network | Dense Feature Reuse | Compound Scaled MBConv |
| **Total Parameters** | 421,601 | 23,503,809 | **~7,000,000** | **~4,000,000** |
| **Trainable Parameters** | 421,601 | 23,503,809 | ~7,000,000 | ~4,000,000 |
| **Classifier Head In-Features** | 128 | 2,048 | 1,024 | 1,280 |
| **Output Logits** | 1 | 1 | 1 | 1 |
| **Pretrained Weights** | None (Random) | `IMAGENET1K_V2` | `IMAGENET1K_V1` | `IMAGENET1K_V1` |
| **Estimated Peak VRAM (AMP, BS=8)** | ~0.8 GB | ~2.5 GB | **~1.8 GB** | **~1.2 GB** |
| **4 GB VRAM Headroom** | Very High (75%) | Safe (37%) | **High (55%)** | **Very High (70%)** |

### 4.2 Architectural Assessment:
- **DenseNet-121**: Densley connected blocks concatenate feature maps from all prior layers, encouraging feature reuse and gradient propagation. Parameter count (7M) is only 30% of ResNet-50. Peak activation memory is well within 4 GB with AMP.
- **EfficientNet-B0**: Uses depthwise separable convolutions and squeeze-and-excitation blocks. Extremely compact (4M params, 17% of ResNet-50) and fast, offering minimal memory overhead and fast epoch times.

---

## 5. Resource-Conscious Training Configuration

The proposed hyperparameters maintain parity with Stage 15 while providing safety margins against CUDA OOM:

```json
{
  "hyperparameters": {
    "epochs": 15,
    "batch_size": 8,
    "accum_steps": 2,
    "effective_batch_size": 16,
    "learning_rate": 0.0001,
    "weight_decay": 0.0001,
    "early_stopping_patience": 5,
    "image_size": [256, 256],
    "num_workers": 2,
    "seed": 42,
    "mixed_precision": true,
    "device": "cuda:0"
  }
}
```

### Key Execution Controls:
1. **Mixed Precision (AMP):** Enabled via `torch.amp.autocast("cuda")` and `torch.amp.GradScaler("cuda")`. Halves activation memory and leverages Tensor Cores on the RTX 2050 (Ampere architecture).
2. **Gradient Accumulation:** 2 steps of accumulation at batch size 8 simulate batch size 16 without peak memory spikes.
3. **VRAM Hygiene:** Pre-run cache purge (`clean_gpu_memory(0)`) and runtime OOM exception catching with diagnostic reporting.
4. **Smoke-Test Mode:** Dedicated `--smoke-test` executing 1 epoch over 32 train and 16 validation samples, completely omitting the test loader.

---

## 6. Consistent Checkpoint Policy & Metrics Specification

To prevent the metric ambiguity analyzed in Stage 15.2, Stage 16 will adopt an explicit, non-conflated dual-checkpoint policy:

### 6.1 Primary Checkpoint (`<model>_best_loss.pt`)
- **Selection Criterion:** **Validation BCE Loss (`val_loss`) minimization**.
- **Rationale:** Preserves calibrated probabilities and balances clinical error rates (aligns with Stage 14 best epoch 7 and Stage 15 best epoch 4).
- **Recorded Metrics:** `epoch`, `val_loss`, `accuracy`, `sensitivity`, `specificity`, `precision`, `f1_score`, `roc_auc`, and confusion matrix `[[TN, FP], [FN, TP]]`.

### 6.2 Secondary Checkpoint (`<model>_best_auc.pt`)
- **Selection Criterion:** **Validation ROC-AUC (`val_roc_auc`) maximization**.
- **Rationale:** Identifies maximum discriminative separation capacity across all operating thresholds.
- **Isolation Rule:** Saved as a distinct file with separate metadata (`selection_metric: "val_roc_auc"`). Metrics from `_best_auc.pt` will be recorded in a dedicated CSV (`stage16_<model>_validation_metrics_auc.csv`) to ensure they are **never conflated** with the primary loss-selected checkpoint.

---

## 7. Test Set Isolation Protocol

- **Strict Blinded Status:** The clean test manifest (644 records) will **not** be evaluated, scored, or tuned against during Stage 16 training.
- **Enforcement:** In the Stage 16 trainer, `evaluate_test` defaults to `False`. The test loader is not initialized during training loops.
- **Audit Requirement:** The clean test partition remains pristine until Stage 17, where all candidate models (Baseline CNN, ResNet-50, DenseNet-121, EfficientNet-B0) will be evaluated once under frozen conditions.

---

## 8. Implementation Plan: Files to Create / Modify

```
cbis-ddsm-breast-cancer/
├── src/
│   ├── models/
│   │   ├── stage16_densenet.py         [NEW: DenseNet-121 with audited pretrained metadata & conv0 adaptation]
│   │   ├── stage16_efficientnet.py     [NEW: EfficientNet-B0 with audited pretrained metadata & conv adaptation]
│   │   └── __init__.py                 [UPDATE: Export Stage 16 models]
│   └── training/
│       └── stage16_trainer.py          [NEW: Unified trainer supporting --model densenet|efficientnet]
├── tests/
│   ├── test_stage16_readiness.py       [CREATED: Readiness audit test suite - 8 tests]
│   └── test_stage16_models.py          [NEW: Model architecture, forward/backward, and checkpoint tests]
├── data/metadata/stage16/
│   ├── stage16_0_readiness_audit.md    [CREATED: This audit document]
│   └── stage16_0_readiness_audit.txt   [CREATED: Plaintext audit document]
└── ref/
    └── todo.md                         [UPDATE: Track Stage 16 milestones]
```

---

## 9. Readiness Test Suite Execution Results

A dedicated test suite [`tests/test_stage16_readiness.py`](file:///c:/Users/swapn/Project/Breast_Cancer/cbis-ddsm-breast-cancer/tests/test_stage16_readiness.py) was constructed and verified against the repository:

1. `test_stage16_manifest_integrity_and_patient_isolation`:
   - Validates 2,239 train, 542 val, 644 test records. Confirms zero patient overlap across active partitions. $\to$ **PASSED**
2. `test_stage16_label_mapping_consistency`:
   - Validates binary labels $\in \{0, 1\}$, 1324/915 train distribution, and 312/230 val distribution. $\to$ **PASSED**
3. `test_densenet121_architecture_and_output_shape`:
   - Validates DenseNet-121 single-channel `conv0`, output shape $(B, 1)$, and ~7.0M parameters. $\to$ **PASSED**
4. `test_efficientnet_b0_architecture_and_output_shape`:
   - Validates EfficientNet-B0 single-channel `features[0][0]`, output shape $(B, 1)$, and ~4.0M parameters. $\to$ **PASSED**
5. `test_grayscale_channel_weight_averaging_densenet`:
   - Validates exact mathematical equality: $W_{\text{gray}} = \text{mean}(W_{\text{rgb}})$ for DenseNet. $\to$ **PASSED**
6. `test_grayscale_channel_weight_averaging_efficientnet`:
   - Validates exact mathematical equality: $W_{\text{gray}} = \text{mean}(W_{\text{rgb}})$ for EfficientNet. $\to$ **PASSED**
7. `test_metric_computations_parity`:
   - Validates exact metric outputs (ROC-AUC 0.78125, Acc 75.0%, F1 75.0%) on standard benchmark vectors. $\to$ **PASSED**
8. `test_prior_stages_immutability`:
   - Confirms that Stages 1–15 manifests, baseline CNN configs, and ResNet-50 checkpoints remain intact. $\to$ **PASSED**

---

## 10. Final Readiness Verdict

### **VERDICT: PASS**

**Supporting Evidence:**
- Zero blockers identified.
- Stage 13 manifests and patient-level zero-leakage splits are 100% verified.
- Memory budget (4 GB VRAM) is easily satisfied by DenseNet-121 (~1.8 GB peak) and EfficientNet-B0 (~1.2 GB peak).
- Grayscale channel weight averaging is mathematically validated for both architectures.
- Dual-checkpoint policy guarantees no metrics conflation.
- The clean test set remains completely unblinded.
- Repository is fully prepared for Stage 16 implementation upon user confirmation.
